Japanese Encephalitis- and Dengue-Associated Acute Encephalitis Syndrome Cases in Myanmar

Aung Kyaw Kyaw1,2, Mya Myat Ngwe Tun2, Takeshi Nabeshima2

  • 1Department of Medical Research (Pyin Oo Lwin Branch), Ministry of Health and Sports, Pyin Oo Lwin, Mandalay Region, Myanmar.

Insights

Japanese encephalitis virus (JEV) and dengue virus (DENV) cause significant encephalitis in Myanmar children. This study confirmed JEV and DENV infections in pediatric acute encephalitis syndrome cases, highlighting the need for surveillance and control.

Area of Science:

  • Virology
  • Epidemiology
  • Pediatrics

Background:

  • Acute encephalitis syndrome (AES) poses a significant health burden in children.
  • Dengue virus (DENV) and Japanese encephalitis virus (JEV) are known flaviviruses causing neurological disease.
  • Limited data exists on the specific burden of DENV and JEV in pediatric AES cases in Myanmar.

Purpose of the Study:

  • To determine the prevalence and burden of DENV and JEV infections in children under 13 presenting with AES.
  • To identify the specific genotypes of DENV and JEV circulating in Myanmar.
  • To provide etiological data for flavivirus encephalitis in the region.

Main Methods:

  • Cerebrospinal fluid (CSF) samples were collected from 123 pediatric AES patients at Mandalay Children Hospital in 2013.
  • Molecular and serological investigations, including neutralization tests and virus isolation, were performed.
  • DENV and JEV specific antibody titers and viral RNA were analyzed.

Main Results:

  • Four cases (3.3%) of JEV-associated encephalitis and one case (0.8%) of DENV-associated encephalitis were confirmed.
  • The highest antibody titers were observed against JEV Genotype 3.
  • A DENV-1 Genotype 1 strain, similar to local and regional strains, was isolated from a dengue encephalitis case.

Conclusions:

  • Flaviviruses, including JEV and DENV, are significant causative agents of encephalitis in children in Myanmar.
  • The findings underscore the importance of flaviviruses in pediatric neurological disease in the region.
  • Enhanced disease surveillance, vector control, and vaccination strategies are crucial to mitigate flavivirus encephalitis morbidity and mortality.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
975
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
325
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
268
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
288
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
427
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
631